Re-inventing tumor targeting
Explore Thermosome’s pipeline
Setting a new standard for the treatment of locally advanced soft tissue sarcoma.
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Thermosome Announces First Patient Dosed in Phase I Trial with Lead Program THE001
BIO International Convention
June 5-8, 2023